Description
Description
Also known as: OGLE-PLGLA1
CAS Number: 910463-68-2
Molecular Formula: C187H291N45O59
Molecular Weight: ~4113.6 g/mol
Form: Lyophilized Powder
Quantity: 10mg
Purity: ≥ 98% (HPLC Verified)
Product Overview:
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist studied in metabolic and endocrine research for its effects on glucose homeostasis, appetite suppression, and energy balance. As an analog of endogenous GLP-1, semaglutide stimulates insulin secretion, suppresses glucagon release, and delays gastric emptying in experimental settings.
Its structure has been modified for enhanced stability and extended half-life, making it a leading compound in obesity and diabetes-related research.
Applications in Research:
-
Models of type 2 diabetes and glycemic regulation
-
Studies of appetite control and caloric intake
-
Investigations into obesity and weight loss mechanisms
-
GLP-1 receptor pathway and insulinotropic effect research
Storage & Handling:
Store lyophilized Semaglutide at -20°C, protected from light and moisture.
Reconstitute using sterile bacteriostatic water. After reconstitution, store at 2–8°C and use within appropriate research timeframes. Avoid repeated freeze-thaw cycles.
⚠️ Research Use Only – Legal Disclaimer
All products on this site are for research and development use only. Products are not for human consumption of any kind. The statements made on this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease.
Simple Peptide is a chemical supplier. Simple Peptide is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Simple Peptide is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act.
All products are sold for research, laboratory, or analytical purposes only, and are not for human consumption.
Reviews
There are no reviews yet.